PMC:7035340 / 3647-4000
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"97","span":{"begin":139,"end":147},"obj":"Species"},{"id":"98","span":{"begin":153,"end":162},"obj":"Species"},{"id":"99","span":{"begin":219,"end":227},"obj":"Species"},{"id":"109","span":{"begin":124,"end":138},"obj":"Disease"},{"id":"110","span":{"begin":215,"end":218},"obj":"Disease"},{"id":"111","span":{"begin":283,"end":287},"obj":"Disease"},{"id":"112","span":{"begin":289,"end":295},"obj":"Disease"},{"id":"113","span":{"begin":299,"end":311},"obj":"Disease"}],"attributes":[{"id":"A97","pred":"tao:has_database_id","subj":"97","obj":"Tax:9606"},{"id":"A98","pred":"tao:has_database_id","subj":"98","obj":"Tax:2697049"},{"id":"A99","pred":"tao:has_database_id","subj":"99","obj":"Tax:9606"},{"id":"A109","pred":"tao:has_database_id","subj":"109","obj":"MESH:D016638"},{"id":"A110","pred":"tao:has_database_id","subj":"110","obj":"MESH:C000657245"},{"id":"A111","pred":"tao:has_database_id","subj":"111","obj":"MESH:D012128"},{"id":"A112","pred":"tao:has_database_id","subj":"112","obj":"MESH:D018805"},{"id":"A113","pred":"tao:has_database_id","subj":"113","obj":"MESH:D012772"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Evidently, all these results strongly suggest that proper use of low-dose corticosteroids may bring survival advantages for critically ill patients with 2019-nCoV, but this treatment should be strictly performed on NCP patients with definite clinical indications (such as refractory ARDS, sepsis or septic shock) according to the recommended guidelines."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T24","span":{"begin":283,"end":287},"obj":"Disease"}],"attributes":[{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Evidently, all these results strongly suggest that proper use of low-dose corticosteroids may bring survival advantages for critically ill patients with 2019-nCoV, but this treatment should be strictly performed on NCP patients with definite clinical indications (such as refractory ARDS, sepsis or septic shock) according to the recommended guidelines."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T17","span":{"begin":74,"end":89},"obj":"Chemical"}],"attributes":[{"id":"A17","pred":"chebi_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/CHEBI_50858"}],"text":"Evidently, all these results strongly suggest that proper use of low-dose corticosteroids may bring survival advantages for critically ill patients with 2019-nCoV, but this treatment should be strictly performed on NCP patients with definite clinical indications (such as refractory ARDS, sepsis or septic shock) according to the recommended guidelines."}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T10","span":{"begin":289,"end":295},"obj":"Phenotype"},{"id":"T11","span":{"begin":306,"end":311},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0100806"},{"id":"A11","pred":"hp_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/HP_0031273"}],"text":"Evidently, all these results strongly suggest that proper use of low-dose corticosteroids may bring survival advantages for critically ill patients with 2019-nCoV, but this treatment should be strictly performed on NCP patients with definite clinical indications (such as refractory ARDS, sepsis or septic shock) according to the recommended guidelines."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T21","span":{"begin":0,"end":353},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Evidently, all these results strongly suggest that proper use of low-dose corticosteroids may bring survival advantages for critically ill patients with 2019-nCoV, but this treatment should be strictly performed on NCP patients with definite clinical indications (such as refractory ARDS, sepsis or septic shock) according to the recommended guidelines."}